Cogent Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $937.6M
Liabilities Breakdown FY2025
Total Liabilities: $301.2M
Asset Breakdown
Total Assets: $937.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $312.0M | 33.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.5M | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $620.1M | 66.1% |
Liabilities Breakdown
Total Liabilities: $301.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.5M | 3.2% |
| Long-Term Debt | $222.9M | 74.0% |
| Other Liabilities | $68.8M | 22.9% |